Delivery Order SPE2DB20D2002-SPE2DB22FL48Q
Award Date
6/21/22
Potential Completion Date
6/22/22
Potential Value
$158K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $41,926.39 order is for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,822.44 firm-fixed-price contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, is fulfilling this order through a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that it holds with DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a specialty pharmaceutical product. The delivery order has a potential value of $1,577.28 and a completion date of February 28, 2024. This order is likely part of Amerisourcebergen Drug Corp's broader indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products, with a potential value of $20,504.64 and a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to support DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The firm fixed price delivery order has a potential value of $1,585.05 and a completion date of December 27, 2023. Amerisourcebergen Drug Corp has an established history of providing pharmaceutical and medical supply products and services to DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The order has a potential value of $18,927.36 and a completion date of January 23, 2024. The order was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and...
This delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency. The $14,178.77 firm fixed price order is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals and medical supplies to the Department of Defense through the Defense Logistics Agency. The company also holds...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product HEPLISAV-B, a 20 mcg/0.5 mL syringe, with a potential value of $124,538.94. The order has a completion date of June 30, 2022 and was awarded on June 29, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp is a for-profit organization that provides pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $31,939.92 and a period of performance through May 15, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The $115,292.00 delivery order had a completion date of October 25, 2021. Amerisourcebergen Drug Corp, as a prime contractor, has an extensive history of providing pharmaceuticals, medical supplies, and distribution services to support...